AMTHRYO
LIVE

Serial Number

79397925

Owner

AMOLYT PHARMA

Attorney

Cara M. Kearney

Filing Date

Apr 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AMTHRYO Trademark

Serial Number: 79397925 • Registration: 7665846

AMTHRYO is a trademark filed by AMOLYT PHARMA on April 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AMOLYT PHARMA (5 trademarks)

15 Chemin du Saquin,

Entity Type: 34

Trademark Details

Filing Date

April 26, 2024

Registration Date

January 28, 2025

Published for Opposition

December 10, 2024

Goods & Services

Pharmaceutical preparations for the treatment of hypoparathyroidism, including eneboparatide.

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 20, 2026 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 20, 2026 CORN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 1, 2025 REAP
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 18, 2025 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Jun 12, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 27, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 9, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 9, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 9, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 9, 2025 COAR
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTICE OF PUBLICATION
Dec 4, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2024 CNSA
ASSIGNED TO EXAMINER
Nov 12, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jul 7, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Jul 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR